Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ku, Il Whea | - |
dc.contributor.author | Cho, Sangwon | - |
dc.contributor.author | Doddareddy, Munikumar Reddy | - |
dc.contributor.author | Jang, Min Seok | - |
dc.contributor.author | Keum, Gyochang | - |
dc.contributor.author | Lee, Jung-Ha | - |
dc.contributor.author | Chung, Bong Young | - |
dc.contributor.author | Kim, Youseung | - |
dc.contributor.author | Rhim, Hyewhon | - |
dc.contributor.author | Kang, Soon Bang | - |
dc.date.accessioned | 2024-01-21T02:05:29Z | - |
dc.date.available | 2024-01-21T02:05:29Z | - |
dc.date.created | 2021-09-01 | - |
dc.date.issued | 2006-10-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/135036 | - |
dc.description.abstract | Morpholin-2-one-5-carboxamide derivatives were prepared by using the one-pot Ugi multicomponent reaction and evaluated for blocking effects on T- and N-type Ca2+ channels. Among them, compound 5i produced the highest potency (IC50 = 0.45 +/- 0.02 mu M), while compounds 5d, 5f, 5k, 5n, 5o, and 6m produced relatively high potency as well as selectivity on T-type Ca2+ channels. These novel scaffolds showed potent and selective T-type Ca2+ channel blocking activities. (c) 2006 Published by Elsevier Ltd. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | CALCIUM-CHANNELS | - |
dc.subject | EFFICIENT SYNTHESIS | - |
dc.subject | IN-VITRO | - |
dc.subject | NEURONS | - |
dc.subject | PAIN | - |
dc.subject | DIVERSITY | - |
dc.subject | SUBUNITS | - |
dc.subject | EPILEPSY | - |
dc.subject | RECEPTOR | - |
dc.title | Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2006.05.031 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.16, no.19, pp.5244 - 5248 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 16 | - |
dc.citation.number | 19 | - |
dc.citation.startPage | 5244 | - |
dc.citation.endPage | 5248 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000240615400051 | - |
dc.identifier.scopusid | 2-s2.0-33747330904 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | CALCIUM-CHANNELS | - |
dc.subject.keywordPlus | EFFICIENT SYNTHESIS | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | NEURONS | - |
dc.subject.keywordPlus | PAIN | - |
dc.subject.keywordPlus | DIVERSITY | - |
dc.subject.keywordPlus | SUBUNITS | - |
dc.subject.keywordPlus | EPILEPSY | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordAuthor | T-type Ca2+ channel | - |
dc.subject.keywordAuthor | mibefradil | - |
dc.subject.keywordAuthor | morpholinone | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.